(See below!) Consensus report on safe use of GLP-1 medications in T1D Despite the fact that GLP-1 receptor agonists (and dual GLP-1/GIP receptor agonists) are not FDA-approved for use in T1D for any indication, people with T1D are still able to access these drugs since they are approved to treat obesity and overweight
They carry over to this month!) Reducing reliance on late-day caffeine and giving the nervous system space to reset Clarity tends to return gradually
they do not inhibit calcineurin but act by inhibiting mTOR kinase (Mika and Stepnowski, 2016)
Exosomes layered with microneedling demonstrated meaningfully better outcomes for scar revision and post-inflammatory hyperpigmentation than microneedling alone in multiple published series
Dungan KM, Povedano ST, Forst T, Gonzlez JGG, Atisso C, Sealls W, et al
Trends Genet (2022) 38(3):23145